Search Results - "OMURO, A. M"

Refine Results
  1. 1

    Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma by YOUNG, R. J, GUPTA, A, SHAH, A. D, GRABER, J. J, ZHANG, Z, SHI, W, HOLODNY, A. I, OMURO, A. M. P

    Published in Neurology (31-05-2011)
    “…To examine the potential utility of conventional MRI signs in differentiating pseudoprogression (PsP) from early progression (EP). This retrospective study…”
    Get full text
    Journal Article
  2. 2

    Primary CNS lymphoma with intraocular involvement : International PCNSL Collaborative Group Report by GRIMM, S. A, MCCANNEL, C. A, HALL, A. J, GRAUS, F, HERRLINGER, U, SCHIFF, D, RAIZER, J, RUBENSTEIN, J, LAPERRIERE, N, THIEL, E, DOOLITTLE, N, IWAMOTO, F. M, OMURO, A. M. P, ABREY, L. E, FERRERI, A. J. M, BLAY, J.-Y, NEUWELT, E. A, SIEGAL, T, BATCHELOR, T, JAHNKE, K, SHENKIER, T. N

    Published in Neurology (21-10-2008)
    “…To describe the demographics, diagnostic details, therapeutic management, and outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. A…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases : a phase I trial by OMURO, A. M, RAIZER, J. J, DEMOPOULOS, A, MALKIN, M. G, ABREY, L. E

    Published in Journal of neuro-oncology (01-07-2006)
    “…Temozolomide (TMZ) has shown modest efficacy in the treatment of recurrent brain metastasis (BM). We designed a new regimen utilizing dose-intensified,…”
    Get full text
    Journal Article
  5. 5

    Cognitive functions in primary CNS lymphoma after single or combined modality regimens by Correa, Denise D., Shi, Weiji, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio M., Deutsch, Mariel B., Thaler, Howard T.

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2012)
    “…The standard treatment for primary CNS lymphoma (PCNSL) involves high-dose methotrexate-based chemotherapy (HD-MTX) alone or in combination with whole brain…”
    Get full text
    Journal Article
  6. 6

    Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma by Young, R J, Gupta, A, Shah, A D, Graber, J J, Schweitzer, A D, Prager, A, Shi, W, Zhang, Z, Huse, J, Omuro, A M P

    Published in American journal of neuroradiology : AJNR (01-12-2013)
    “…Epidermal growth factor receptor amplification is a common molecular event in glioblastomas. The purpose of this study was to examine the potential usefulness…”
    Get full text
    Journal Article
  7. 7

    Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification by Gupta, A., Young, R. J., Shah, A. D., Schweitzer, A. D., Graber, J. J., Shi, W., Zhang, Z., Huse, J., Omuro, A. M. P.

    Published in Clinical neuroradiology (Munich) (01-06-2015)
    “…Background and Purpose Molecular and genetic testing is becoming increasingly relevant in GBM. We sought to determine whether dynamic susceptibility contrast…”
    Get full text
    Journal Article
  8. 8

    EGFR tyrosine kinase domain mutations in human gliomas by MARIE, Y, CARPENTIER, A. F, OMURO, A. M. P, SANSON, M, THILLET, J, HOANG-XUAN, K, DELATTRE, J.-Y

    Published in Neurology (26-04-2005)
    “…Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor effective in patients with lung cancer with mutations in exons 19 and 21 of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas? by Omuro, Antonio M, Delattre, Jean-Yves

    Published in Current opinion in neurology (01-12-2008)
    “…To critically assess the role of irinotecan (Camptosar, CPT-11) and bevacizumab (Avastin) as a new treatment for glioblastoma and other malignant gliomas…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    AI-09 PATTERNS OF SALVAGE TREATMENT FOR HIGH GRADE GLIOMA IN THE TEMOZOLOMIDE ERA by Escorcia, F. E., Folkert, M. R., Spratt, D. E., Zumsteg, Z., Chan, T., Omuro, A. M., Beal, K., Gutin, P. H., Yamada, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)
    “…PURPOSE: High grade gliomas (HGGs) are aggressive malignancies that recur despite trimodality treatment with surgery, radiation therapy (RT), and temozolomide…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20